Schizophrenia Research
Volume 73, Issue 2 , Pages 193-207, 1 March 2005

Targeting synapses and myelin in the prevention of schizophrenia

  • T.-U.W. Woo

      Affiliations

    • Massachusetts Mental Health Center, Boston, MA 02115, United States
    • Program in Structural and Molecular Neuroscience, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States
    • Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Harvard Medical School, 115 Mill Street, Belmont 02478, United States. Tel.: +1 617 998 0075; fax: +1 617 998 5007.
  • ,
  • A.L. Crowell

      Affiliations

    • Massachusetts Mental Health Center, Boston, MA 02115, United States
    • Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States
    • Current address: Stanford University School of Medicine, Stanford, CA, USA.

Received 11 June 2004; received in revised form 26 July 2004; accepted 30 July 2004.

Abstract 

Many of the functions that are mediated by the prefrontal cortex (PFC) are severely impaired in schizophrenia. The maturation of these functions takes place during late adolescence and early adulthood, which coincides with the period of time when overt symptomatology of schizophrenia most commonly emerges. Two developmental processes occurring during the periadolescence period appear to mediate the functional maturation of the PFC: pruning of exuberant synapses and myelination of axons. It has long been speculated in the literature that disturbances of these processes may result in dysfunction of the PFC and thereby trigger the emergence of symptoms and deficits of schizophrenia. Alternatively, but not mutually exclusively, it has also been suggested that these late developmental processes may not be aberrant but they “unmask” preexisting deficits in the PFC, resulting in the onset of symptoms. The important implication of both of these scenarios is that in either case the emergence of PFC functional disturbances and the onset of symptoms and deficits of schizophrenia would in theory be preventable by pharmacologic manipulation of the synaptic pruning and/or axonal myelination processes. Thus, better understanding of the cellular and molecular mechanisms that mediate these processes will provide truly novel insight into the therapeutics and prevention of schizophrenia.

Keywords: Prodrome, GABA, Puberty, Development, Prefrontal cortex

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(04)00242-7

doi:10.1016/j.schres.2004.07.022

Schizophrenia Research
Volume 73, Issue 2 , Pages 193-207, 1 March 2005